Zurueck zur Suche

Reporte zur Charge 3NA4M

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

19Reporte angezeigt
0Todesfaelle
0Hospitalisiert
1Lebensbedrohlich
0Bleibende Schaeden
CA 10 IA 1 UT 1 AZ 1 MT 1 TX 1 FL 1 IL 1 WI 1 MS 1

VAERS 2228972

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 3NA4M

schwer
Staat
CA
Alter
20,0
Geschlecht
F
Eingang
12.04.2022
Impfdatum
11.04.2022
Beginn
11.04.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Hyperhidrosis Loss of consciousness Pallor Syncope

Symptomtext

4/11/2022 @2:10PM 20yo female came in for flu and t-dap vaccination was accompanied by mom. Vaccine information sheets (VIS) were distributed to the patient along with health screening questionnaire by the vaccinator. While the vaccines were being prepared, the health screening questionnaire was distributed to the patient and filled out by the patient. The questionnaire was reviewed by vaccinator prior vaccinating. Patient marked yes on question #4 regarding long term health problems, stating that she has Asthma and is using an inhaler. There were no observed contraindications with the flu or T-dap based upon the patients? self-report. The patient asked if it is normal to feel nauseous after getting flu vaccine. Patient concern was answered accordingly and there weren?t any further questions. At approximately 2:18PM T-dap was first given on the left arm, then the vaccinator proceeded with flu quadrivalent vaccine given on the right arm. The patient was observed to be fine while the vaccinator was inputting shot records into system. The vaccinator stepped out their room to print the patient?s shot record, 10 feet away with office door open. The vaccinator heard mom calling to patient, asking if she was okay. The vaccinator ran into the room and the patient?s mother stating, ?she?s fainting.? The patient stated, ?I?m going to faint.? The vaccinator kept the patient in her seat and leaned the patient backwards to prevent her from falling forward. The patient appeared pale, diaphoretic, and briefly became unconscious. The vaccinator then grabbed the O2 tank behind the door and yelled for help. The vaccinator noted that the patient woke back up within 10 seconds. PHN came in to assist immediately. At 2:24 pm O2 was administered via non-rebreather mask @8L/min. O2 was at 100%, BP 114/84, HR 93, AOX3. During the vital sign assessment, the patient?s color gradually returned. Water and hard candy were offered to the patient. The vaccinator offered to call EMS, the patient declined the offer with mom room, stating, ?I have no insurance.? The patient declined with the patient?s mother present. At 2:29 pm vital signs were reassessed. BP 122/84, HR 84, O2 98%, and AOX3. The patient intermittently used their O2 mask. PHN asked if the patient needed us to call an ambulance for her. The patient declined. The vaccinator advised the patient about emergency insurance. During the observation mom and patient state that it is common for her to faint after getting vaccinated and this was not her first time. This was not communicated at any time prior to immunization. The patient was observed to be stable. Around 2:55 pm, the patient and mom were ready to leave, and the vaccinator had the patient stand. The patient self-reported and stated that she felt dizzy and said that she was going to faint. The vaccinator then sat the patient back down. O2 @10L/min was administered via NRM. BP 140/90, HR 83, AOX3 and O2 100%. The patient began to complain of chest pain/tightness with a pain of 4 out of 10. The patient then became lethargic. In the meantime, LVN, tried to call clinical doctors for advice. PHN asked again if the patient would like us to call EMS for assistance, stating that he?d be more comfortable with healthcare monitoring her on the way to the hospital. The patient?s mother stated that she would like the same, but the patient refused the idea of calling an ambulance, citing that she did not have insurance. 3:00 pm BP 140/100, HR 84, O2 100%, AOX3, with O2 given at 10L/min via NRM. The patient continued to present lethargic. LVN offered to call an ambulance and patient declined with the patient?s mother and PHN and the vaccinator present. At 3:10 pm the BP was unable to be obtained. HR 83, O2 99%, with no O2 administered. Lower back pain and chest pain were noted at a level of 4 out of 10. PHN stated that he was not comfortable with the patient?s chest pain and lethargy, and that he felt that she should be taken by ambulance to the emergency room and once again asked the patient if she would like for us to call EMS. The patient declined. LVN and PHN Continued to monitor patient while I called Dr. at 3:13 pm and left a message stating the patient?s condition, assessment, and vital signs. At 3:19 pm, BP 138/72, HR 93, O2 98%, AOX3, with no O2 administration. Patient continued to present lethargic. Pain level was a 4 out of 10. In both the chest and back. LVN stated that she felt that the patient should be sent out via ambulance and offered to call EMS once again. Patient declined. Mom had called relative to help with driving the patient to hospital, with the patient?s refusal to have EMS called. At 3:39 pm, Dr. called the vaccinator back and reaffirmed that ?patient should go to the ER.? At that time, the staff offered to call EMS so that the patient could be taken to the hospital via ambulance. The mother agreed that she felt it would be best, not knowing what she would do if the patient passed out again. The patient refused the idea of being taken to the hospital via ambulance. At 03:40 pm, BP 140/90, HR 90, AOX3, and O2 98%. The patient was assisted to the car via wheelchair by staff at 3:57 pm.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
NO
Vorgeschichte
ASTHMA
Andere Medikamente
INHALER
Allergien
NO
Vorherige Impfungen
-

VAERS 1888362

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 3na4m

schwer
Staat
IA
Alter
16,0
Geschlecht
F
Eingang
20.11.2021
Impfdatum
20.11.2021
Beginn
20.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Abdominal discomfort Cough Loss of consciousness Malaise Pallor Syncope

Symptomtext

Within minutes of receiving the vaccine, patient reported not feeling well. Upset stomach, coughing and color going from face. Patient sat down and proceeded to lose consciousness briefly and possible have a seizure. Patient came back to consciousness in seconds and was able to converse as pharmacist was on call with 911/EMS. Patient improved in condition to the point of conversating with parents and reported feeling much better. EMS came and assessed the patient reported to believe it was a syncope episode, offered ambulance to ER but declined by parents. Will call patient tomorrow Sunday to see if anything else progressed/treatment was performed.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
None to the date of submitting
Aktuelle Erkrankungen
Slight sore throat but no fever and reported feeling okay
Vorgeschichte
N/A
Andere Medikamente
Unknown/None
Allergien
no known allergies
Vorherige Impfungen
-

VAERS 1861588

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 3NA4M

schwer
Staat
CA
Alter
43,0
Geschlecht
M
Eingang
11.11.2021
Impfdatum
01.11.2021
Beginn
03.11.2021
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Deep vein thrombosis Fibrin D dimer Pain in extremity Peripheral swelling Ultrasound Doppler abnormal

Symptomtext

Pain in my right foot began on Wed. morning. Pain and swelling spread from foot to lower right leg. Intense pain Friday night. Symptoms were similar to blood clot, and a blood clot was suspected so I went to the ER Saturday (11-6). DVT was confirmed (11-6).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Deep vein thrombosis
Hospital-Tage
-
Labordaten
D-dimer and ultrasound were preformed to evaluated whether it was a clot (Sat. morning, Nov. 6). Tests indicated that is was.
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
None
Allergien
none
Vorherige Impfungen
-

VAERS 1848995

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 3NA4M

schwer
Staat
CA
Alter
7,0
Geschlecht
M
Eingang
06.11.2021
Impfdatum
06.11.2021
Beginn
06.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Fall Loss of consciousness Pallor Skin warm

Symptomtext

Client received the Pfizer COVID vaccine (lot#FK1527) in the L deltoid and the Fluarix Quadrivalent Influenza Vaccine (Lot#3NA4M) in the R deltoid at approximately 1050 from vaccinator RN. After the client received both vaccines, he stood up to wait next to his mother who was receiving her COVID vaccine from the same vaccinator. Due to a limited supply of chairs at the mobile event there was not an available chair to allow the client to sit down while waiting with his mother. At approximately 1055, as the client was standing next to his mother, he began to slouch over the vaccination table and vaccinator RN's assisted client to the ground. Client lost consciousness for approximately 2 seconds. RN assessed non obstructed airway, no respiratory distress, and raised the client's legs while he was laying on the floor. RN assessed client who presented with mild pallor of the face, no diaphoresis, and pupils equal and reactive. RN took client vitals at 1103 with BP 100/60 in the L arm laying down, 70 HR, and 16 RR. Lead RN assessed client at 1103 presented A&O x4 and talking in full sentences, grip strong and equal, cap refill < 3 seconds, and skin pink and warm to touch. Client's mother reported that the client ate breakfast at 0830 and had a muffin. Client denied dizziness, SOB, headache, numbness, or tingling. Client was assisted to zero-gravity chair and Lead RN advised that the client be observed for 30 minutes. Client's father reported that he has a history of fainting but reported that the client has never fainted in the past. Lead RN provided client with water, juice, and graham crackers. Client took sips of the water and juice and ate his snacks. Client reported to Lead RN that he was "feeling good now" and denied any dizziness, SOB, headache, numbness, or tingling. RN reviewed when to f/u with PCP. At 1140 the client left the vaccine site with his parents. Client walked out of the vaccine site with a steady and symmetrical gait.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2091859

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 3NA4M

moderat
Staat
CA
Alter
10,0
Geschlecht
F
Eingang
06.02.2022
Impfdatum
08.11.2021
Beginn
08.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pallor Somnolence Tremor

Symptomtext

Client reported feeling nauseous to RN after receiving the Fluarix Quadrivalent vaccine. RNs responded. RN noted the client appeared pale and was holding an emesis bag provided by RN. The client stood up and transferred to the anti-gravity chair without assistance. The anti-gravity chair was placed in a semi-fowler's position. RN noted trembling of the client's legs bilaterally. RN offered the client water or juice and the client declined. RN provided the client with a cotton swab with peppermint oil on it and the client began smelling the peppermint oil. The client then agreed to take a small sip of juice. The client stated she did not like the juice. The client's mother reported the client ate an egg sandwich this morning. The client and her mother denied any chronic conditions, medications, or known allergies. The client's mother reported that the client has a history of feeling nervous when receiving vaccines and "other situations." Vitals obtained with the pulse oximeter at 12:31PM were as follows: HR 80 and O2 97%. The client stated that she was feeling better, denied any current nausea, and reported persistent trembling. Vitals obtained at 12:35PM were as follows: BP 110/79, HR 76, O2 99%. The client ambulated unassisted with a steady gait to the observation area at 12:38 PM. The client sat in the anti-gravity chair in the observation area. The client began drinking water. Vitals obtained at 12:45 PM were as follows: BP 122/77, HR 96, O2 97%. Vitals obtained at 12:51 PM were as follows: BP 146/79, HR 78, O2 99%. Repeat blood pressure taken at 12:54PM was 108/70. The reported feeling "sleepy" but denied any other symptoms. RN provided education regarding s/s of anaphylaxis and when to seek EMS. The client and her mother voiced understanding of this education. The client ambulated with a steady gait out of the vaccination site at 12:55PM.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tremor
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown
Vorgeschichte
None
Andere Medikamente
None
Allergien
NKA
Vorherige Impfungen
-

VAERS 1910470

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 3NA4M

moderat
Staat
UT
Alter
33,0
Geschlecht
F
Eingang
30.11.2021
Impfdatum
04.11.2021
Beginn
04.11.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injected limb mobility decreased Injection site pain Shoulder injury related to vaccine administration

Symptomtext

L shoulder pain and decreased ROM which peaked at 48 hrs post-injection and persists at a mild level on Nov 30. Pharmacist injected vaccines in close proximity to each other and and a relatively high level on the arm. Findings c/w SIRVA.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
none
Vorgeschichte
seasonal allergies, mild intermittent asthma, ADHD
Andere Medikamente
ibuprofen, Sprintec, montelukast, Adderall, hydroxyzine
Allergien
none
Vorherige Impfungen
-

VAERS 1890570

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 3NA4M

moderat
Staat
CA
Alter
39,0
Geschlecht
F
Eingang
22.11.2021
Impfdatum
22.11.2021
Beginn
22.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Disorientation Dizziness Extra dose administered Paraesthesia

Symptomtext

Client stated, "I was sitting in my chair for 2 minutes and then I began to feel a rush to my head. It felt like a wave of tingling all over my body and I started to feel disoriented for like 10 seconds. I then felt fine but I said to myself I need to get up and let the nurse know." Secondary RN helped transfer client into anti-gravity chair at 12:05 PM. First set of vitals were then taken at that time by Observation RN prior to Co Lead PHN responding to observation room: BP 115/75, pulse 60, O2 SAT 100%, 16 respirations per minute. At 12:08 PM Co Lead PHN advised client to take face mask off and for client to take deep breaths. Client was offered water and snacks but client declined snacks and already had a water bottle. Client stated, "I am not surprised I felt like this after the shot because back when I received my first Janssen shot the next day I felt slight chest tightness while driving. It only lasted for 15 seconds then I felt fine. I am not sure if it was due to the covid-19 vaccine so I didn't feel the need to let my doctor know." Co Lead PHN clarified whether she was short of breath during that experience while driving to which client said "no." Client stated, "I felt like I was gasping for air and not so much choking. It only lasted for 15 seconds while I was driving and I then felt fine." Client then disclosed to Co Lead PHN, "I've had similar experiences with blood draws where I feel like I'm going to faint." Client does not have any medical conditions nor is taking any medications. Client has no history of allergies. Client did state, "I am sensitive to soaps, lotions, and I always take half the dose of any medication." Co Lead PHN observed client to be A&Ox4 throughout entire conversation. Co lead PHN recommended for client to follow up with PCP regarding post vaccination symptoms and to enroll in V-SAFE. Client stated, "I have an appointment with my PCP on Tuesday, I will let them know." At 12:16 PM secondary RN educated the client on when to call 911 or go to urgent care for adverse symptoms of covid-19 vaccination. Client verbalized understanding. Co Lead PHN recommended for client to call a family member to assist the client in driving home to which client declined because she only lives 1 mile away from vaccination site. Co Lead PHN recommended for one last set of vitals after another 10 minutes of monitoring. at 12:27 PM Secondary RN took last set of vitals: BP LA 115/70, pulse 64, O2 SAT 100%. Client expressed she was ready to go home. At 12:31 PM Co Lead PHN walked with client as standby assist towards the exit of vaccination site. Client walked with steady gait and thanked us for assisting her.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 1865598

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 3NA4M

moderat
Staat
AZ
Alter
39,0
Geschlecht
F
Eingang
12.11.2021
Impfdatum
27.10.2021
Beginn
27.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Abdominal pain Dizziness Flushing Hypoaesthesia Immediate post-injection reaction Paraesthesia Throat tightness Tunnel vision

Symptomtext

Within approximately 1 minute after receiving the vaccine, I felt sharp abdominal pains, followed by my throat closing up, facial flushing, numbness and tingling, as well as tunnel vision and feeling like I was going to pass out.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1954995

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge 3NA4M

mild
Staat
MT
Alter
28,0
Geschlecht
F
Eingang
16.12.2021
Impfdatum
15.10.2021
Beginn
01.12.2021
Tage bis Beginn
47,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Abdominal pain Full blood count Heavy menstrual bleeding Laboratory test normal Menstrual disorder Nausea Urine analysis normal

Symptomtext

Patient presented to the ED with complaints of abnormal vaginal bleeding and abdominal cramping . Patient had her last normal menses on November 24, ending on the 27th. On December 1, she started spotting and then had heavier bleeding with some nausea

Weitere VAERSDATA-Felder
Praegender Schweregrund
Abdominal pain
Hospital-Tage
-
Labordaten
CBC, Chemistry and urine studies completed and within normal limits.
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
no known allergies
Vorherige Impfungen
-

VAERS 1880336

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 3NA4M

mild
Staat
TX
Alter
4,0
Geschlecht
M
Eingang
18.11.2021
Impfdatum
11.11.2021
Beginn
12.11.2021
Tage bis Beginn
1,0
Dosis
7+
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Erythema Urticaria

Symptomtext

After vaccines, patientt developed redness to the site on both arms, but 48 hrs later he had large whelp to left upper arm (Kinrix); 72 hrs had hives all over his body. Bendryl did not help patient, was started on oral steroids Nov 17th

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Tonsillitis-10/28/2021
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 1858040

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 3NA4M

mild
Staat
FL
Alter
59,0
Geschlecht
M
Eingang
10.11.2021
Impfdatum
19.10.2021
Beginn
23.10.2021
Tage bis Beginn
4,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia X-ray limb

Symptomtext

Right Shoulder Pain.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
Right Shoulder X Ray
Aktuelle Erkrankungen
N/A
Vorgeschichte
HTN, DM
Andere Medikamente
Lisinopril, Crestor, Januvia
Allergien
N/A
Vorherige Impfungen
-

VAERS 1808758

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 3NA4M

mild
Staat
CA
Alter
29,0
Geschlecht
F
Eingang
22.10.2021
Impfdatum
22.10.2021
Beginn
22.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dizziness Exposure during pregnancy Headache

Symptomtext

Pregnant client. 22 weeks pregnant. Due date is 02/22/2022.10 minutes after vaccination, the client reports feeling light headed. Client's vitals stable. She sat in an anti-gravity chair for over 30 minutes. Client reported feeling well to drive herself home, but that she did have a slight headache.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None reported
Vorgeschichte
Anxiety, PTSD
Andere Medikamente
Client takes zofran and prenatal vitamins
Allergien
None
Vorherige Impfungen
-

VAERS 1785418

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 3NA4M

mild
Staat
IL
Alter
45,0
Geschlecht
F
Eingang
14.10.2021
Impfdatum
05.10.2021
Beginn
06.10.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Burning sensation Lymphadenopathy Pain Skin warm Somnolence

Symptomtext

45-year-old female RN was received a flu shot and COVID shot on 10/05/2021. She reports she after the she developed pain with subsequent drowsiness and intense burning on the ventral surface of her proximal her upper extremities (in the proximity of the biceps brachi) and axilla?s She felt that she felt that her lymph nodes were swollen as well. She fells that he area is warm as well. She had not had reactions to immunizations previously. She tells me that she has been using Tylenol and Ibuprofen 800. She denies fevers or recent illness. She reports a Hx of Migraine headaches and uses Rrizatriptan, Emgality and drospirenone-ethinyl estradiol OCP. She denies possibility of pregnancy or allergies. She reports a 5/10 constant burning pain with no aggravating factors on the left and a 2/10 constant burning pain with no aggravating factors on the right.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain
Hospital-Tage
-
Labordaten
CBC/CMP ordered
Aktuelle Erkrankungen
Denies
Vorgeschichte
Migraine Headaches
Andere Medikamente
Rrizatriptan, Emgality and drospirenone-ethinyl estradiol OCP
Allergien
Denies
Vorherige Impfungen
-

VAERS 1775266

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 3na4m

mild
Staat
CA
Alter
54,0
Geschlecht
F
Eingang
09.10.2021
Impfdatum
01.10.2021
Beginn
06.10.2021
Tage bis Beginn
5,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site bruising Injection site pain

Symptomtext

patient received flu vaccine 10/1/2021 . one week later she called and informed us she felt sore, bruising and pain at injectionsite

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site bruising
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
not known
Vorgeschichte
not known
Andere Medikamente
not known
Allergien
not known
Vorherige Impfungen
-

VAERS 2468024

UNKNOWN MANUFACTURER · INFLUENZA (SEASONAL) (NO BRAND NAME) · Charge 3NA4M

gering
Staat
WI
Alter
-
Geschlecht
U
Eingang
04.10.2022
Impfdatum
26.09.2022
Beginn
26.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

expired Flu vaccine administered; This case was reported by a pharmacist via sales rep and described the occurrence of expired vaccine used in an unspecified number of patients who received Flu unspecified (Flu vaccine) (batch number 3NA4M, expiry date 30th June 2022) for prophylaxis. On 26th September 2022, the patient received Flu vaccine. On 26th September 2022, unknown after receiving Flu vaccine, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. Additional Information: GSK receipt date: 26-Sept-2022 Reporter's comment: The pharmacist stated that GlaxoSmithKline Flu vaccine 2021-22 formulation was administered to more than 20 employees during their fall 2022 flu campaign on the day of reporting. The reporter did not had additional details regarding recipient names, but will obtain it from nursing personnel. The reporter asked to mail form to complete additional details. No adverse clinical sequelae had been reported by recipients at this time. The reporter consented to follow-up. Additional supportive information: The patients had received an expired dose of Flu vaccine, which led to expired vaccine used.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1904568

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 3NA4M

gering
Staat
CA
Alter
10,0
Geschlecht
M
Eingang
28.11.2021
Impfdatum
06.11.2021
Beginn
20.11.2021
Tage bis Beginn
14,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Chest discomfort

Symptomtext

On Saturday, November 27, 2021 client came for vaccination POD accompanied by his Mother for his second Covid-19 Pfizer pediatric dose. During assessment questions, Mom stated to RN, patient received his first dose Covid-19 Pfizer pediatric dose (LOT #: FK5127) on 11/6/21 in his right arm and and a flu shot on his left arm. Two weeks later, Mom stated patient experienced a "pinching sensation" on left side of chest. Mom stated patient would experience this sensation once or two times a day intermittently. The last time it happened was on 11/25/21, Thanksgiving day. Mom stated they spoke with his MD who recommended a 30 minute wait after second vaccination. Patient has no chronic medical conditions and takes Loratadine every day due to allergies to cats and dust. Lead Nurse elevated to Vaccine Operations Lead who was on site, who consulted with County MD. Per County MD, Pfizer pediatric dose was approved and advised client to receive his second dose of Pfizer Covid-19 vaccine with 30 minute observation. Client was vaccinated with Covid-19 Pfizer vaccine (LOT #: FK5618) in his left arm at 2:07 PM. Client and client's Mother was educated by RN on signs and symptoms of adverse reactions and when to go to the ED/call MD. Client's Mother was also encouraged to sign-up on v-safe. Client experienced no adverse reaction while waiting in Observation Area and left vaccination site with a steady gait at 2:45 pm.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest discomfort
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
Loratadine
Allergien
cats, dust
Vorherige Impfungen
-

VAERS 1846850

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 3NA4M

gering
Staat
CA
Alter
10,0
Geschlecht
M
Eingang
05.11.2021
Impfdatum
04.11.2021
Beginn
04.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Underdose

Symptomtext

Client received the Fluarix Quadrivalent vaccine (Lot#3NA4M, exp. 06/30/22) from vaccinator at approximately 1700 in the R deltoid. During administration of the vaccine, the client pulled his arm away abruptly causing some of the Fluarix Quadrivalent vaccine to be wasted on the clients R arm and on his chair. RN was unable to determine the amount of vaccine that was wasted. Lead Vaccinator elevated concern to the Clinical Operations team. Clinical Operations received guidance from County MD that re vaccination is indicated the following day. RN communicated this with client's mother who verbalized understanding. RN received guidance from the clinical operations team that the vaccination should still be documented as administered since the client did receive some of the Fluarix Quadrivalent vaccine dose. No adverse affects were reported during the client's observation of 15 minutes.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 1842435

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 3na4m

gering
Staat
MS
Alter
52,0
Geschlecht
F
Eingang
04.11.2021
Impfdatum
27.10.2021
Beginn
27.10.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered

Symptomtext

fluarix vaccine was give to a patient on 2 separate days; This case was reported by a nurse via call center representative and described the occurrence of extra dose administered in a 52-year-old female patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2021-2022 season) (batch number 3na4m, expiry date 30th June 2022) for prophylaxis. Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis. Concomitant products included INFLUENZA VIRUS VACCINE INACTIVATED (FLUARIX TETRA PFS). On 27th October 2021, the patient received the 2nd dose of Fluarix Quadrivalent 2021-2022 season and Fluarix Tetra Pre-Filled Syringe Device. On 27th October 2021, unknown after receiving Fluarix Quadrivalent 2021-2022 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The flu fluarix vaccine was given to a patient on two separate days, which led to extra dose administered. The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1794343

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 3NA4M

gering
Staat
CA
Alter
25,0
Geschlecht
M
Eingang
17.10.2021
Impfdatum
17.10.2021
Beginn
17.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Interchange of vaccine products

Symptomtext

Client received the 1st COVID vaccine Janssen (Lot #1822809 exp 03/07/2022) at 3:01PM and the Fluarix Quadrivalent vaccine (Lot # 3NA4M exp 06/3/2022) at 3:07PM. After receiving both vaccines, the client disclosed to RN that he had received a Moderna COVID vaccine about 2 weeks ago. The client stated he received the 1st dose of COVID vaccine Moderna "about two weeks ago." The client stated that he did not have any documentation of the Moderna COVID vaccine and was unsure what location he received the vaccine. Prior to receiving the COVID vaccine Janssen RN had asked the client if he had received any other COVID vaccines. The client denied having received any previous COVID vaccine. The client denied any s/s of anaphylaxis. RN recommended the client wait 30 minutes in the observation area. The client voiced understanding of this education. RN checked in with database representative, who stated no records appeared when they searched the client in database prior to receiving the COVID vaccine Janssen. Representative again searched the client in database and RN verified no records appeared. RN returned to the client. The client denied any current symptoms. The client stated that his 30 minutes had elapsed since he received the COVID vaccine Janssen. The client stood up unassisted and left the vaccination site at 3:20PM. After the client left the vaccination site, Representative noted a record matching client information received the 1st COVID vaccine Moderna (Lot#058E21A exp 01/10/2022).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Interchange of vaccine products
Hospital-Tage
-
Labordaten
CL
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-